Introduced in the late 1990s, continuous glucose monitoring (CGM) revolutionized diabetes care. Prior to CGM, home blood glucose monitoring (BGM) methodologies – which involve patients using a lancet to prick their fingers and apply a drop of blood to a test strip – represented the norm. Still, even with the rise of CGM, several challenges remain. That's what Glucotrack Inc. is looking to address.
In particular, while current CGM solutions have improved quality of life via informed decision-making, several obstacles – including discomfort and inconvenience – have left many patients as well as medical professionals wanting. Glucotrack aims to fill the opportunity gaps in the CGM industry by directly addressing the pain points of the contemporary standard of care.
In particular, while current CGM solutions have improved quality of life via informed decision-making, several obstacles – including discomfort and inconvenience – have left many patients as well as medical professionals wanting. Glucotrack aims to fill the opportunity gaps in the CGM industry by directly addressing the pain points of the contemporary standard of care.
Category
🗞
NewsTranscript
00:00The world of diabetes management is evolving rapidly.
00:06For years, people with diabetes relied on finger pricks to monitor their blood glucose.
00:11Then came continuous glucose monitors, or CGMs, offering more frequent data.
00:16However, these devices still have major drawbacks.
00:19Short lifespans, inconsistent accuracy when compared to finger stick blood glucose systems,
00:24wearables that could cause skin irritation or fall off prematurely, and more.
00:28Enter Glucotrack, a company determined to revolutionize diabetes care.
00:33They've developed a groundbreaking system that significantly improves upon what's come
00:37before to deliver a system that transforms care, a continuous blood glucose monitoring
00:42system, or CBGM.
00:44What makes this technology so special?
00:46First, it's completely hidden.
00:48No external components to worry about.
00:50A tiny device fully implanted under your skin.
00:54Second, it measures glucose directly from your blood, not interstitial fluid, giving
00:58you real-time accuracy.
01:00Third, it's designed to provide accurate readings for up to three years without the
01:04hassles of traditional CGMs that sometimes last as little as a few weeks.
01:09And it requires minimal calibration, making your life easier.
01:13In a survey of over 750 people, over half of current and former CGM users expressed
01:19interest in this new device.
01:21They were drawn to its long lifespan, direct blood glucose measurements, and the absence
01:25of any wearable components.
01:27Recently, the company has reported promising data from preclinical studies.
01:31As Paul Good, PhD president and CEO of Glucotrack states,
01:35We are very pleased with the performance of our sensor during a long-term preclinical
01:40study and look forward to moving into human clinical trials.
01:43The company sees uses beyond diabetes care too.
01:46They're exploring how this technology could help with other conditions, like painful
01:50diabetic neuropathy.
01:52By measuring glucose in the epidural space, they hope to improve the quality of life for
01:56even more patients.
01:58This is the evolution of diabetes monitoring.
02:01It's about setting new standards in accuracy, convenience, and independence.
02:05With Glucotrack, the future of diabetes care looks brighter than ever.